- Coordinator
- Universita Degli Studi Di Udine, Italy
- Runs
- 1 January 2026 to 31 December 2029
- Status
- Running
- EU funding
- €4.5m
- Total cost
- —
- Partners
- 28 organisations in 11 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101226670
What the project is doing
In the project's own words, from its summary on CORDIS.
In recent years, nucleic acids (NAs) have contributed significantly to advancing the diagnosis and treatment of diseases such as cancer, infectious and rare diseases. Breakthrough technologies like genome editing tool CRISPR/Cas9, direct RNA sequencing, multi-omics analysis procedure for NAs analysis, bioinformatics and machine learning for data analysis, and targeted delivery systems based on lipid nanoparticles (LNPs) prove the increasing interest in NAs applicability.
However, the full potential of NAs is yet to be unlocked, and the translation of NAs into clinical practice is still facing many methodological and technological limitations such as low detection sensitivity, limited sequencing capacity, lack of analytical methods for NAs therapeutics, and inadequate in vivo delivery. INT2ACT brings together 6 academic research units and 5 industrial partners to address these limitations by establishing new methods for detecting and analysing NAs in patient liquid biopsies, boosting available procedures for direct RNA sequencing, developing new methods for the synthesis and analysis of antisense oligonucleotides (ASO) libraries, identifying new RNA targets, and optimise NA therapeutics delivery systems.
The concept of harnessing NAs in the realm of medicine opens doors to an array of possibilities, including the development of therapeutic vaccines for cancer and innovative ASO-based therapies for addressing a multitude of genetic disorders. While advancing NAs’ research and technologies, INT2ACT will also contribute to forming the next generation of highly skilled experts through an interdisciplinary and intersectoral training programme delivered to 15 Doctoral Candidates.
The network-wide training programme is designed to ensure that all INT2ACT fellows will have the skills for a successful career in or outside of research in any sector.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universita Degli Studi Di Udine | Udine | Italy | Coordinator |
| Accelopment Schweiz AG | Zurich | Switzerland | Associatedpartner |
| Shanghai University | Shanghai | China | Associatedpartner |
| Baseclick GmbH | Neuried | Germany | Participant |
| Ludwig-Maximilians-Universitaet Muenchen | Planegg | Germany | Associatedpartner |
| Asociacion Instituto De Investigacion Sanitaria Biogipuzkoa | Donostia-San Sebastian | Spain | Participant |
| Flomics Biotech SL | Barcelona | Spain | Participant |
| Fundacio Universitat Pompeu Fabra(barcelona) | Barcelona | Spain | Associatedpartner |
| Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea | Leioa | Spain | Associatedpartner |
| National Institute for Bioprocessing Research and Training Limited | Blackrock Dublin | Ireland | Participant |
| University College Dublin, National University of Ireland, Dublin | Dublin | Ireland | Participant |
| Mana Bio Ltd | Tel Aviv | Israel | Associatedpartner |
| Technion - Israel Institute of Technology | Haifa | Israel | Associatedpartner |
| Technion Research and Development Foundation Ltd | Haifa | Israel | Participant |
| Center for Ethics in Science and Science Journalism - Centro per L'etica Nella Scienza E Nel Giornalismo Scientifico | Milano | Italy | Associatedpartner |
| Fondazione Istituto Italiano Di Tecnologia | Genova | Italy | Participant |
| Istituto Nazionale Di Biostrutture E Biosistemi | Roma | Italy | Associatedpartner |
| Istituto Universitario Di Studi Superiori ( I.u.s.s.) Di Pavia | Pavia | Italy | Associatedpartner |
| Instytut Chemii Bioorganicznej Polskiej Akademii Nauk | Poznan | Poland | Participant |
| Oneki AB | Stockholm | Sweden | Associatedpartner |
| Astrazeneca UK Limited | Cambridge | United Kingdom | Associatedpartner |
| Careers Research and Advisory Centre (crac) Limited (the) | Cambridge | United Kingdom | Associatedpartner |
| Nanovery Ltd | Newcastle Upon Tyne | United Kingdom | Associatedpartner |
| Nanovery Ltd | Newcastle Upon Tyne | United Kingdom | Participant |
| University of Newcastle Upon Tyne | Newcastle Upon Tyne | United Kingdom | Associatedpartner |
| University of Newcastle Upon Tyne | Newcastle Upon Tyne | United Kingdom | Participant |
| University of Southampton | Southampton | United Kingdom | Participant |
| Johns Hopkins University | Baltimore | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS